CDC’s ACIP Will Meet on Oct. 19 and 20 to Review Use of Immunizations; Will Consider Adding COVID Jabs to Childhood Schedule

On October 19 and 20, the Centers For Disease Control and Prevention (CDC) will hold an open meeting of the Advisory Committee on Immunization Practices (ACIP) to review and possibly revise the use of immunizations—including the child/adolescent immunization schedule to include mRNA COVID-19 vaccines, among others. This could enable school COVID vaccine mandates for children, and give the pharmaceutical companies complete liability protection.

The meeting will be held on October 19, 2022, from 8:30 a.m. to 5:30 p.m., EDT and October 20, 2022, from 8:30 a.m. to 3:20 p.m., EDT, and will be webcast live, the CDC announced.

Matters To Be Considered: The agenda will include discussions on influenza vaccines, pneumococcal vaccine, meningococcal vaccines, respiratory syncytial virus vaccine, rotavirus vaccine, dengue vaccines, adult immunization schedule, child/adolescent immunization schedule, COVID-19 vaccines and Chikungunya vaccine. Recommendation votes on pneumococcal, adult immunization schedule, child/adolescent immunization schedule and COVID-19 vaccines are scheduled. A Vaccines for Children (VFC) vote on COVID-19 vaccine is scheduled.

The public may submit comments on Docket No. CDC-2022-0111, by either of the following methods:

• Federal eRulemaking Portal: https://www.regulations.gov . Follow the instructions for submitting comments.

• Mail: Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS H24-8, Atlanta, GA 30329-4027, Attn: October 19-20, 2022, ACIP Meeting.

Instructions: All submissions received must include the Agency name and Docket Number. All relevant comments received will be posted without change to https://www.regulations.gov, including any personal information provided. For access to the docket to read background documents or comments received, go to https://www.regulations.gov .

Written comments can be left here, and must be received on or before October 20, 2022.

Just last week, the U.S. Food and Drug Administration (FDA) amended the Emergency Use Authorizations (EUAs) for the new Pfizer and Moderna COVID-19 Omicron booster shots for children as young as five years old, despite having no safety data of the shots in children.

CDC Director Dr. Rochelle Walensky quickly signed off on the boosters without meeting with the CDC’s independent panel of vaccine experts.

“FDA’s authorization of updated (bivalent) COVID-19 vaccines for this younger age group, and CDC’s recommendation for use, are critical next steps forward in our country’s vaccination program,” CDC officials said in a statement.

Whistleblower Brook Jackson pointed out on Twitter Monday that as the CDC considers adding the mRNA jabs to the childhood vaccine schedule, her case against Pfizer is still pending.

Jackson was the regional director for the Ventavia Research Group, the company that was conducting Pfizer’s pivotal phase III trial in Texas in 2020.

In September of 2020, Jackson emailed a complaint to the FDA, informing the agency of the company’s allegedly dangerous and shoddy research practices. The FDA took no action on her email, and Pfizer continued to use the company.

Ventavia fired her after she tried to expose the alleged fraud, abuse, and protocol violations she witnessed during the trials.

Robert F. Kennedy Jr., an environmental lawyer and icon of the anti-vaccine movement, has been warning that once the COVID jab is on the childhood vaccination schedule, the vaccine makers are permanently shielded from liability for injuries and deaths that occur in any age group, including adults. Kennedy said first step of securing permanent legal indemnity for Big Pharma was when the FDA and CDC included COVID vaccines for children under the EUA, even though the vast majority of children are not at risk of serious SARS-CoV-2 infection, and the risks far outweigh the benefits.

Here are the latest VAERS numbers on vaccine injuries in children, via the Defender.

VAERS data from Dec. 14, 2020, to Oct. 7, 2022, for 6-month-olds to 5-year-olds show:

VAERS data from Dec. 14, 2020, to Oct. 7, 2022, for 12- to 17-year-olds show:

  • 39,833 adverse events, including 4,335 rated as serious and 127 reported deaths. According to the CDC, “VAERS data available to the public include only the initial report data to VAERS. Updated data which contains data from medical records and corrections reported during follow up are used by the government for analysis. However, for numerous reasons including data consistency, these amended data are not available to the public.”

  • 269 reports of anaphylaxis among 12- to 17-year-olds where the reaction was life-threatening, required treatment or resulted in death.

  • 1,332 reports of myocarditis and pericarditis with 1,163 cases attributed to Pfizer’s vaccine.

  • 301 reports of blood clotting disorders with 278 cases attributed to Pfizer.

  • 26 cases of postural orthostatic tachycardia syndrome (POTS) with all cases attributed to Pfizer’s vaccine.

“The Emergency Use Authorization vaccines have liability protection through the PREP Act and CARES Act, so as long as there’s emergency use, you can’t sue them,” Kennedy explained during an interview earlier this year.

This is of monumental importance given the 31,470 deaths and 1,437,273 reports of adverse events from all age groups in the United States following COVID-19 vaccines.

“Once they get approved, now you can sue them—unless they can get it recommended for children,” Kennedy continued. “All vaccines that are officially recommended for children get liability protection even if an adult gets that vaccine.”

He added: “That’s why they’re going after kids. They know this is going to kill and injure a huge number of children, but they need to do it for the liability protection.”

“The stark truth we now face is that the FDA and CDC are no longer in the business of protecting public health,” wrote osteopathic physician and author Dr. Joseph Mercola at the Defender back in July. “They are securing profits for the drug industry, and getting EUA for infants and young children is a crucial step toward securing permanent legal indemnity for the drug makers.”

Mercola argued that “the reason the FDA and CDC are acting so irrationally and ignoring safety signals is because they are not working to protect you. They’re working for the drug industry, and they’ve just sold out our children.”

“The end goal is to give drug companies permanent immunity against liability for injury and death from the COVID shots in all age groups and to get there, they first need the EUA to cover all children,” he explained.

“After that, the Advisory Committee on Immunization Practices’ approval becomes more or less a matter of rubber stamping,” Mercola continued. “This is what they’ve become, and I see no future in which these two agencies survive. All we need is enough people to understand what they’ve done, and that day is coming.”

Get the news corporate media won't tell you.

Get caught up on today's must read stores!

By submitting your information, you agree to receive exclusive AG+ content, including special promotions, and agree to our Privacy Policy and Terms. By providing your phone number and checking the box to opt in, you are consenting to receive recurring SMS/MMS messages, including automated texts, to that number from my short code. Msg & data rates may apply. Reply HELP for help, STOP to end. SMS opt-in will not be sold, rented, or shared.

About Debra Heine

Debra Heine is a conservative Catholic mom of six and longtime political pundit. She has written for several conservative news websites over the years, including Breitbart and PJ Media.

Photo: SEATTLE, WA - JUNE 21: A 20-month-old baby receives the first dose of the Pfizer Covid-19 vaccination at UW Medical Center - Roosevelt on June 21, 2022 in Seattle, Washington. Covid-19 vaccinations for children younger than 5 began today across the U.S. (Photo by David Ryder/Getty Images)